Dynamic Allocation of Pharmaceutical Detailing and Sampling for Long-Term Profitability

Montoya, Ricardo; Netzer, Oded; Jedidi, Kamel
September 2010
Marketing Science;Sep/Oct2010, Vol. 29 Issue 5, p909
Academic Journal
The U.S. pharmaceutical industry spent upwards of $18 billion on marketing drugs in 2005; detailing and drug sampling activities accounted for the bulk of this spending. To stay competitive, pharmaceutical managers need to maximize the return on these marketing investments by determining which physicians to target as well as when and how to target them. In this paper, we present a two-stage approach for dynamically allocating detailing and sampling activities across physicians to maximize long-run profitability. In the first stage, we estimate a hierarchical Bayesian, nonhomogeneous hidden Markov model to assess the short- and long-term effects of pharmaceutical marketing activities. The model captures physicians' heterogeneity and dynamics in prescription behavior. In the second stage, we formulate a partially observable Markov decision process that integrates over the posterior distribution of the hidden Markov model parameters to derive a dynamic marketing resource allocation policy across physicians. We apply the proposed approach in the context of a new drug introduction by a major pharmaceutical firm. We identify three prescription-behavior states, a high degree of physicians' dynamics, and substantial long-term effects for detailing and sampling. We find that detailing is most effective as an acquisition tool, whereas sampling is most effective as a retention tool. The optimization results suggest that the firm could increase its profits substantially while decreasing its marketing spending. Our suggested framework provides important implications for dynamically managing customers and maximizing long-run profitability.


Related Articles

  • SEMI-REGENERATIVE PROCESSES WITH UNBOUNDED REWARDS. Schellhaas, Helmut // Mathematics of Operations Research;Feb79, Vol. 4 Issue 1, p70 

    A semi-regenerative process (SRP) is combined with a reward structure such that the accumulated reward during [0, t] is the sum of a functional of the SRP and a functional of the embedded Markov renewal process (MRP). For the expected (discounted) return a Markov renewal equation (MRE) is given....

  • Big pharma finally taking big steps to reach patients with digital media. Miley, Marissa; Thomaselli, Rich // Advertising Age;5/11/2009, Vol. 80 Issue 17, p8 

    The article reports that the pharmaceutical industry is expanding its Internet marketing through Web 2.0 means such as blogs and online social networks. The highly regulated industry has been one of the last to embrace such means of reaching consumers. Internet marketing spending by...

  • Best Practices: consumer marketing success is different for every product. Liebman, Milton // Medical Marketing & Media;Oct2002, Vol. 37 Issue 10, p22 

    Reports on the consumer marketing for the pharmaceuticals in the U.S. Allocation of the staff budget to advertising; Commercialization of the products; Variation of the return on investment.

  • Evaluating CPOE systems: Key comparative criteria you'll need to consider.  // Formulary;Mar2002, Vol. 37 Issue 3, p157 

    Evaluates the benefits of the computerized provider order entry (CPOE) system. Limitations of the CPOE systems; Reduction of the incidence of medication errors; Need for enhancements of the system.

  • The six scariest letters in the marketing alphabet. Schultz, Don E. // Marketing News;11/20/95, Vol. 29 Issue 24, p6 

    Suggests the separation of brand building from business building for better estimation of a marketing program's return on investment (ROI). Reasons for marketing and communications groups' difficulty in estimating ROI.

  • Jump Dynamics And Volatility Components For OECD Stock Returns. Guesmi, Khaled; Akbar, Farhan; Kazi, Irfan A.; Chkili, Walid // Journal of Applied Business Research;May/Jun2013, Vol. 29 Issue 3, p777 

    The paper applies Markov Regime Switching Model (MRSM) to investigate the volatility behaviour of twelve OECD stock markets (U.S.A, France, Ireland, Netherlands, Spain, Denmark, Norway, Sweden, Switzerland, UK, Australia and Japan) for the period 2004-2010. The results highlight two different...

  • An Analysis of the Control-Algorithm Re-solving Issue in Inventory and Revenue Management. Secomandi, Nicola // Manufacturing & Service Operations Management;Summer2008, Vol. 10 Issue 3, p468 

    While inventory- and revenue-management problems can be represented as Markov decision process (MDP) models, in some cases the well-known dynamic-programming curse of dimensionality makes it computationally prohibitive to solve them exactly. An alternative solution, called here the...

  • Editorial. Satchell, Stephen E // Journal of Asset Management;Jun2008, Vol. 9 Issue 1, p1 

    The author reflects on the economic models being used by companies in estimating financial data. He mentions about the regime-switching model which is based on Markov processes as well as the Levy procedure. He further affirms that though there are still questions being raised regarding the...

  • Pharma Spends More on Meetings. Pelletier, Sue; Hosansky, Tamar // Medical Meetings;Mar/Apr2003, Vol. 30 Issue 2, p71 

    Reports on the result of a study presented by professor Dick Wittink on the return on investment (ROI) for drug marketing dollars in the U.S. Percentage increase in physician meetings and events spending according to the study; Other promotion areas included in the study; Definition of ROI.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics